Advisors Preferred LLC Acquires Shares of 90,149 Privia Health Group, Inc. (NASDAQ:PRVA)

Advisors Preferred LLC purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 90,149 shares of the company's stock, valued at approximately $2,137,000. Advisors Preferred LLC owned about 0.08% of Privia Health Group as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Loomis Sayles & Co. L P boosted its holdings in Privia Health Group by 1.2% during the third quarter. Loomis Sayles & Co. L P now owns 623,870 shares of the company's stock worth $14,349,000 after buying an additional 7,577 shares during the last quarter. Walleye Capital LLC bought a new position in Privia Health Group during the third quarter worth about $1,394,000. Vanguard Group Inc. boosted its holdings in Privia Health Group by 0.5% during the third quarter. Vanguard Group Inc. now owns 11,003,989 shares of the company's stock worth $253,092,000 after buying an additional 51,317 shares during the last quarter. Great Lakes Advisors LLC bought a new position in Privia Health Group during the third quarter worth about $3,534,000. Finally, Envestnet Asset Management Inc. boosted its holdings in Privia Health Group by 33.6% during the third quarter. Envestnet Asset Management Inc. now owns 455,626 shares of the company's stock worth $10,479,000 after buying an additional 114,568 shares during the last quarter. Institutional investors own 94.48% of the company's stock.

Privia Health Group Stock Performance

NASDAQ PRVA traded up $0.19 during trading on Friday, hitting $18.57. The stock had a trading volume of 652,244 shares, compared to its average volume of 979,492. The company has a market capitalization of $2.20 billion, a PE ratio of 97.74, a P/E/G ratio of 2.49 and a beta of 0.81. The company's 50-day moving average price is $20.50 and its two-hundred day moving average price is $21.68. Privia Health Group, Inc. has a 12 month low of $17.54 and a 12 month high of $30.15.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its earnings results on Tuesday, February 27th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.02). Privia Health Group had a net margin of 1.39% and a return on equity of 3.97%. The firm had revenue of $440.80 million during the quarter, compared to the consensus estimate of $425.81 million. During the same quarter in the previous year, the firm posted $0.14 EPS. The company's revenue was up 21.0% on a year-over-year basis. As a group, equities analysts anticipate that Privia Health Group, Inc. will post 0.26 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PRVA has been the topic of a number of research analyst reports. Barclays initiated coverage on Privia Health Group in a research report on Wednesday, March 6th. They set an "equal weight" rating and a $22.00 price target on the stock. UBS Group dropped their price target on Privia Health Group from $31.00 to $29.00 and set a "buy" rating on the stock in a research report on Friday, March 1st. JPMorgan Chase & Co. dropped their price target on Privia Health Group from $38.00 to $30.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 6th. Evercore ISI dropped their price target on Privia Health Group from $26.00 to $25.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 28th. Finally, Bank of America lowered Privia Health Group from a "buy" rating to a "neutral" rating and dropped their price target for the stock from $27.00 to $21.00 in a research report on Thursday, February 22nd. Two investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $28.58.

Insider Transactions at Privia Health Group

In other news, CFO David Mountcastle sold 3,933 shares of the company's stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total transaction of $69,889.41. Following the sale, the chief financial officer now owns 262,279 shares in the company, valued at approximately $4,660,697.83. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CFO David Mountcastle sold 3,933 shares of the business's stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total transaction of $69,889.41. Following the transaction, the chief financial officer now directly owns 262,279 shares of the company's stock, valued at approximately $4,660,697.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William M. Sullivan sold 9,951 shares of the business's stock in a transaction that occurred on Wednesday, January 24th. The stock was sold at an average price of $23.03, for a total value of $229,171.53. Following the transaction, the director now directly owns 5,464,533 shares in the company, valued at $125,848,194.99. The disclosure for this sale can be found here. Company insiders own 57.60% of the company's stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.